Have a personal or library account? Click to login
Biologic Therapy in Inflammatory Bowel Disease - Results from a Single Tertiary Care Center in North Macedonia Cover

Biologic Therapy in Inflammatory Bowel Disease - Results from a Single Tertiary Care Center in North Macedonia

PRILOZI
Volume 44 (2023): Issue 2 (July 2023)
By: Gjorgi Deriban,  Dafina Nikolova,  Fani Licoska,  Emilija Trpcevska Nikolovska,  Vladimir Andreevski,  Kalina Stardelova and  Vladimir Serafimoski  
Open Access
|Jul 2023
DOI: https://doi.org/10.2478/prilozi-2023-0023 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 41 - 46
Published on: Jul 15, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Inflammatory bowel disease,
Crohn’s disease,
Ulcerative colitis,
Biological therapy,
Infliximab,
Adalimumab
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2023 Gjorgi Deriban, Dafina Nikolova, Fani Licoska, Emilija Trpcevska Nikolovska, Vladimir Andreevski, Kalina Stardelova, Vladimir Serafimoski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 44 (2023): Issue 2 (July 2023)Next article